The mechanism of reactivation of telomerase in cancers has been recently reported to take place by recruitment of transcription factor such as GABPA (Akincilar et al., 2016) or BRAF (Li et al., 2016) specifically to mutant TERT promoters, hence driving TERT transcription. The gene discussed is BRAF; the disease is cancer.